Literature DB >> 6792884

CT of the adverse effects of therapeutic radiation of the central nervous system.

D P Kingsley, B E Kendall.   

Abstract

Clinical deterioration during or after radiation of the central nervous system may be due to progression of, or a complication induced in, the lesion being treated. Deterioration may also be due to an adverse effect of the radiation on nervous tissue or vessels within the beam, to alteration in the blood-brain barrier, thus influencing the effects of drug therapy, or to a superimposed catastrophe unrelated to the treatment. Transient effects, which occur within the first 3 months of radiotherapy, include increase in symptoms suggesting enlargement of the tumor and the somnolence syndrome that occurs in children. Classical permanent radiation effects include necrosis, atrophy, calcification, necrotizing leukoencephalopathy, mineralizing microangiopathy, aneurysm formation, tumor induction, and cerebrospinal fluid fistulae. Rarely, demyelination occurs with higher doses than are currently used. The permanent effects tend to occur later than the transient ones; some are progressive and many have serious consequences. The appearances of mineralizing microangiopathy are specific; but the nature of the other complications is only evident in the clinical context, although there may be difficulty distinguishing between radiation necrosis and further growth of an intracerebral tumor. Selected cases illustrate the computed tomographic features of these entities.

Entities:  

Mesh:

Year:  1981        PMID: 6792884      PMCID: PMC8333286     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  10 in total

1.  Endovascular glue embolization of a radiation-induced lenticulostriate artery pseudoaneurysm in a pediatric patient with optic pathway glioma: Case report and review of literature.

Authors:  Satya Narayana Patro; Daniela Iancu; Taleb Al Mansoori; Howard Lesiuk; Michael Vassilyadi
Journal:  Interv Neuroradiol       Date:  2018-05-31       Impact factor: 1.610

Review 2.  Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies.

Authors:  Nishant Verma; Matthew C Cowperthwaite; Mark G Burnett; Mia K Markey
Journal:  Neuro Oncol       Date:  2013-01-16       Impact factor: 12.300

3.  Cerebral radionecrosis: is surgery necessary?

Authors:  E Woo; K Lam; Y L Yu; P W Lee; C Y Huang
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-11       Impact factor: 10.154

4.  Anterior communicating artery aneurysm following radiation therapy for optic glioma: report of a case and review of the literature.

Authors:  Kemal Yucesoy; Iman Feiz-Erfan; Robert F Spetzler; Patrick P Han; Stephen Coons
Journal:  Skull Base       Date:  2004-08

5.  Effect of voxel position on single-voxel MR spectroscopy findings.

Authors:  P E Ricci; A Pitt; P J Keller; S W Coons; J E Heiserman
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

6.  Neurosarcoidosis.

Authors:  Aljoeson Walker; William Tyor
Journal:  Curr Treat Options Neurol       Date:  2001-11       Impact factor: 3.598

7.  Radiation necrosis of the brain: time of onset and incidence related to total dose and fractionation of radiation.

Authors:  H Safdari; J M Fuentes; J B Dubois; M Alirezai; P Castan; B Vlahovitch
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

8.  Neuroradiological features of six kindreds with MELAS tRNA(Leu) A2343G point mutation: implications for pathogenesis.

Authors:  C M Sue; D S Crimmins; Y S Soo; R Pamphlett; C M Presgrave; N Kotsimbos; M J Jean-Francois; E Byrne; J G Morris
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

9.  Rapid progression of early delayed radiation effect in pleomorphic xanthoastrocytoma.

Authors:  Kyung Jae Park; Shin-Hyuk Kang; Hoon Kap Lee; Yong Gu Chung
Journal:  J Korean Neurosurg Soc       Date:  2009-12-31

10.  Neurosarcoidosis.

Authors:  Ashok V Patel; David E Stickler; William R Tyor
Journal:  Curr Treat Options Neurol       Date:  2007-05       Impact factor: 3.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.